Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate gvax and ipilimumab

Saskia J.A.M. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed, Helen Gall, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Rik J. Scheper, Winald R. Gerritsen, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate gvax and ipilimumab'. Together they form a unique fingerprint.

Medicine & Life Sciences